ovarian neoplasm
|
0.370 |
Biomarker
|
disease |
BEFREE |
The hub gene BIRC5, which might play a key role in ovarian neoplasms, was further screened.
|
31177266 |
2019 |
ovarian neoplasm
|
0.370 |
Biomarker
|
disease |
BEFREE |
An increasing number of studies have confirmed that survivin (BIRC5) plays essential roles in ovarian cancer.
|
29499854 |
2018 |
ovarian neoplasm
|
0.370 |
Biomarker
|
disease |
BEFREE |
Hedgehog signaling pathway has been implicated in the pathology of ovarian cancer, and Survivin (BIRC5) has been suggested as a novel target of this pathway.
|
29039491 |
2017 |
ovarian neoplasm
|
0.370 |
AlteredExpression
|
disease |
BEFREE |
Collectively, our studies demonstrated that disruption of BIRC5 expression inhibited EMT by attenuating the TGFβ pathway in ovarian cancer cells.
|
29212257 |
2017 |
ovarian neoplasm
|
0.370 |
AlteredExpression
|
disease |
LHGDN |
Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.
|
18842333 |
2009 |
ovarian neoplasm
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
|
18567002 |
2008 |
ovarian neoplasm
|
0.370 |
AlteredExpression
|
disease |
LHGDN |
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
|
18593915 |
2008 |
ovarian neoplasm
|
0.370 |
Biomarker
|
disease |
CTD_human |
Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients.
|
18567002 |
2008 |
ovarian neoplasm
|
0.370 |
AlteredExpression
|
disease |
LHGDN |
The prognostic significance of COX-2 and survivin expression in ovarian cancer.
|
18171606 |
2008 |
ovarian neoplasm
|
0.370 |
Therapeutic
|
disease |
CTD_human |
[Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
|
16202317 |
2005 |
ovarian neoplasm
|
0.370 |
Biomarker
|
disease |
CTD_human |
Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.
|
16211241 |
2005 |
ovarian neoplasm
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells.
|
15970709 |
2005 |
ovarian neoplasm
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.
|
16211241 |
2005 |
ovarian neoplasm
|
0.370 |
Biomarker
|
disease |
CTD_human |
[Influence of short hairpin RNA on survivin mRNA expression and chemosensitivity to paclitaxel in ovarian cancer cells].
|
16202317 |
2005 |
ovarian neoplasm
|
0.370 |
Biomarker
|
disease |
CTD_human |
Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells.
|
15970709 |
2005 |